PEGylation improves the hypoglycaemic efficacy of intranasally administered glucagon-like peptide-1 in type 2 diabetic db/db mice

scientific article published on 22 November 2007

PEGylation improves the hypoglycaemic efficacy of intranasally administered glucagon-like peptide-1 in type 2 diabetic db/db mice is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1463-1326.2007.00823.X
P698PubMed publication ID18034839

P2093author name stringLee S
Lee KC
Chae SY
Jeon JE
Youn YS
P2860cites workA role for glucagon-like peptide-1 in the central regulation of feedingQ24314317
Intranasal delivery of PEGylated salmon calcitonins: hypocalcemic effects in rats.Q33193338
Nasal drug delivery--possibilities, problems and solutionsQ35078394
Concept, strategies, and feasibility of noninvasive insulin deliveryQ35615559
Therapeutic strategies based on glucagon-like peptide 1.Q35872582
Brain uptake of the glucagon-like peptide-1 antagonist exendin(9-39) after intranasal administrationQ48094330
Synthesis, characterization, and pharmacokinetic studies of PEGylated glucagon-like peptide-1.Q53864082
P433issue4
P304page(s)343-346
P577publication date2007-11-22
P1433published inDiabetes, Obesity and MetabolismQ5270109
P1476titlePEGylation improves the hypoglycaemic efficacy of intranasally administered glucagon-like peptide-1 in type 2 diabetic db/db mice
P478volume10

Reverse relations

cites work (P2860)
Q49630159Advances in micro- and nanotechnologies for the GLP-1-based therapy and imaging of pancreatic beta-cells
Q38089879Designing PEGylated therapeutic molecules: advantages in ADMET properties
Q38628696Glucagon-Like Peptide-1 Formulation--the Present and Future Development in Diabetes Treatment
Q42557469Glucagon-like peptide-1 functionalized PEG hydrogels promote survival and function of encapsulated pancreatic beta-cells
Q33858681Inhalable PEGylated Phospholipid Nanocarriers and PEGylated Therapeutics for Respiratory Delivery as Aerosolized Colloidal Dispersions and Dry Powder Inhalers
Q57369611Natural and Synthetic Polymers as Drug Carriers for Delivery of Therapeutic Proteins
Q27023585Oral delivery of glucagon-like peptide-1 and analogs: alternatives for diabetes control?
Q38298423Synthesis and Evaluation of a Series of Long-Acting Glucagon-Like Peptide-1 (GLP-1) Pentasaccharide Conjugates for the Treatment of Type 2 Diabetes.
Q39039567Unsaturated glycoceramides as molecular carriers for mucosal drug delivery of GLP-1.

Search more.